Pharmaceutical companies AbbVie and Genentech partner with TrumpRx Hub for the administration’s ‘Most-Favored-Nation’ pricing plan.
TrumpRx Launches Discounted Prescription Drugs Recently, two significant pharmaceutical companies have joined the effort to provide discounted medications at White House stores. TrumpRx, an initiative aimed at making prescription drugs more affordable, has seen participating companies expand. In line with the administration’s Most Favored Nation (MFN) program, AbbVie and Genentech are now offering their prescription […]
Trump signs order to enforce 100% tariff on brand-name medications — pharmaceutical industry responds
Trump’s Executive Order on Drug Tariffs President Donald Trump recently announced a new executive order aimed at implementing tariffs on branded medications, with the intention of reducing the United States’ reliance on drug imports. In his statement, the president expressed that these tariffs, which will reach as high as 100%, are necessary for national security […]
$400 Billion in Pharmaceutical Production Returning to the U.S.
Commerce Secretary Discusses Drug Manufacturing Shift to the U.S. During a recent policy forum organized by Breitbart News, Commerce Secretary Howard Lutnick shared insights that $400 billion in drug manufacturing is set to return to the United States, largely due to policies from the Trump administration. “We’re aiming to provide more affordable medications in America, […]
AI company Tempus secures $1.1 billion in data agreements with leading pharmaceutical firms
Tempus AI Reports Record Growth and Customer Engagement 2026/01/11 – 5:30 PM Tempus AI, Inc. has shared preliminary, unaudited data showcasing a substantial revenue of approximately $316 million for the year 2025. This marks a 31% increase from the previous year, driven notably by a 38% growth in their Insight (data license) segment. The net […]
Pharmaceutical companies plan to increase prices on 350 drugs in the US, even with pressure from President Trump.
Pharmaceutical companies are set to increase prices for at least 350 brand-name medications in the U.S., which includes vaccines for COVID-19, respiratory syncytial virus, shingles, and the popular cancer treatment Ibrance. This information comes from healthcare research firm 3Axis Advisors, despite ongoing pressure from President Trump for price reductions. The number of drugs facing price […]
Ex-FDA official reveals surprising misinformation in the pharmaceutical industry about depression
Understanding Depression Diagnosis: A Different Perspective Many individuals think that diagnosing clinical depression is all about objective tests, like blood tests or brain scans. However, Dr. Josef Witt-Doerring challenges this notion, suggesting that it’s not quite as straightforward as that. He points out that when diagnosing depression, people are asked to select from nine symptoms. […]
Marty Makary praises Trump’s FDA actions to address excessive pharmaceutical advertisements with ‘Pod Force One’
FDA Takes Action on Drug Advertising President Trump’s administration is stepping up efforts to regulate the overwhelming number of drug advertisements that Americans encounter daily, according to FDA Commissioner Marty McCulley during a recent appearance on “Pod Force One.” “It’s really becoming a problem,” McCulley shared with host Miranda Devine. “The relationship between doctors and […]
Trump confronts pharmaceutical companies that exploit ill Americans for profits
Trump’s Recent Deal with Big Pharma: Lower Costs, But at What Cost? Recently, President Trump signed another agreement, this time with a major pharmaceutical company, aimed at reducing costs for patients in the U.S. The industry is urging collaboration to support consumers and boost domestic production. Ironically, however, these same companies have raised prices across […]
Eli Lilly achieves a $1 trillion market value — the first pharmaceutical company to do so
Eli Lilly achieved a significant milestone on Friday, hitting a market capitalization of $1 trillion. This makes it the first pharmaceutical company to break into a realm typically associated with tech giants, highlighting its emergence as a leader in the weight-loss sector. This year, the company’s stock has surged over 35%, largely fueled by the […]
Trump reaches significant agreement with pharmaceutical companies Lilly and Novo regarding obesity medications and Medicare.
Addressing America’s Obesity Crisis Robert F. Kennedy Jr., the Secretary of Health and Human Services, is currently focused on pinpointing the underlying reasons behind the obesity epidemic in the United States. At the same time, the Trump administration aims to ensure affordable access to medications for diabetes and weight loss, particularly targeting glucagon-like peptide-1 receptor […]